Ticacip 90 Mg Tab

TICACIP 90 MG Tablet

TICACIP 90 MG Tablet is an antiplatelet medication used to prevent serious cardiovascular events. It is manufactured by CIPLA HEALTH LIMITED. The generic name for this medicine is Ticagrelor, which is also widely known by the brand name Brilinta.

Composition

• Active Ingredient: Each tablet contains 90 mg of Ticagrelor.

Uses

TICACIP 90 MG Tablet is primarily used to reduce the risk of heart attack, stroke, and other cardiovascular events in high-risk patients. It works by preventing platelets from sticking together and forming harmful blood clots. Specifically, it is prescribed for:

• Patients with acute coronary syndrome (ACS), including unstable angina and heart attacks.
• Patients with a history of heart attack or stroke.
• To lower the risk of blood clots in individuals who have received stents to treat ACS.
• To reduce the risk of a first heart attack or stroke in patients with coronary artery disease (CAD) who are at high risk for such events.

Dosage and Administration

TICACIP 90 MG Tablet can be taken with or without food, preferably at the same time every day. The dosage typically involves:

• Initial Loading Dose: A single dose of 180 mg (two 90 mg tablets) is often given at the start of treatment.
• Maintenance Dose: Followed by 90 mg twice a day. For patients with ACS, this is usually continued for 12 months.
• In some cases, for extended therapy beyond one year in high-risk patients with a history of MI, a reduced maintenance dose of 60 mg twice daily may be used.
• TICACIP 90 MG Tablet is often prescribed along with a low-dose aspirin (75 mg to 100 mg daily). Higher doses of aspirin (above 100 mg daily) may reduce Ticagrelor's effectiveness.
• If unable to swallow whole, tablets can be crushed and mixed with water.

Side Effects

Common side effects of TICACIP 90 MG Tablet include:

• Bleeding or bruising (e.g., nosebleeds, taking longer for bleeding to stop).
• Dyspnea (shortness of breath).
• Dizziness or headache.
• Nausea and diarrhea.
• Increased uric acid levels in the blood (hyperuricemia), potentially leading to gout symptoms.

Serious side effects are rare but can include severe allergic reactions, uncontrollable bleeding, or severe shortness of breath.

Precautions

• Bleeding Risk: TICACIP 90 MG Tablet increases the risk of bleeding. Patients should be cautious with sharp objects and avoid situations where injury might occur.
• Contraindications: Do not use if you have a history of intracranial hemorrhage or active pathological bleeding (e.g., stomach ulcer). Severe liver impairment is also a contraindication.
• Surgery: Inform your doctor or dentist if you are taking this medicine before any surgery or dental procedure. It may need to be discontinued at least 5 days prior to reduce bleeding risk.
• Drug Interactions:
  • Avoid strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin) as they can significantly increase Ticagrelor exposure and bleeding risk.
  • Co-administration with other anticoagulants or antiplatelets requires strict medical supervision due to increased bleeding risk.
  • Avoid consuming alcohol as it can increase the risk of bleeding.
• Discontinuation: Do not stop taking TICACIP 90 MG Tablet without consulting your doctor, as sudden discontinuation can increase the risk of heart attack or stroke.
• Pregnancy and Breastfeeding: Use with caution during pregnancy and breastfeeding; consult a doctor.
• Children: Safety and effectiveness in children under 18 have not been established.

Storage

Store TICACIP 90 MG tablets at room temperature, between 68°F to 77°F (20°C to 25°C). Keep medicines out of the sight and reach of children.

Here are the most frequently asked questions about TICACIP 90 MG TAB, an antiplatelet medication containing Ticagrelor.

What is TICACIP 90 MG TAB used for?

TICACIP 90 MG TAB is primarily used to reduce the risk of heart attack, stroke, and cardiovascular death in high-risk patients, particularly those with acute coronary syndrome (ACS) or a history of myocardial infarction. It also helps prevent blood clots in people with coronary artery disease and after procedures like stent placement.

How does TICACIP 90 MG TAB work?

TICACIP 90 MG TAB contains Ticagrelor, which is an antiplatelet drug. It works by reversibly blocking P2Y12 adenosine diphosphate (ADP) receptors on platelets. This action prevents platelets from sticking together and forming harmful blood clots, thereby improving blood flow through the arteries and reducing the risk of heart-related events.

What is the usual dosage for TICACIP 90 MG TAB?

The typical dosage can vary. Often, treatment begins with a loading dose, usually 180 mg (two 90 mg tablets) followed by a maintenance dose of 90 mg twice a day for a specified period (e.g., 12 months). In some cases, after 12 months, the dose may be reduced to 60 mg twice a day. It is usually taken with a low dose of aspirin. Always follow your doctor's specific instructions on dosage and duration. The tablet can be taken with or without food.

What are the possible side effects of TICACIP 90 MG TAB?

Common side effects include bleeding (e.g., nosebleeds, bruising, bleeding gums), shortness of breath (dyspnea), dizziness, headache, nausea, and diarrhea. Less common but more serious side effects can include severe bleeding (e.g., in the brain or stomach) or liver problems. If you experience any severe or persistent side effects, contact your doctor immediately.

Is TICACIP 90 MG TAB safe during pregnancy or breastfeeding?

TICACIP 90 MG TAB is generally not recommended during pregnancy or if you are trying to conceive due to limited safety information and the potential for harm to the unborn baby. For breastfeeding, it is unknown if Ticagrelor passes into human milk, although levels are likely low. An alternative drug may be preferred, especially for newborns or premature infants. If used, monitor the infant for bruising and bleeding. Always consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Can TICACIP 90 MG TAB be taken with other medications?

TICACIP 90 MG TAB can interact with several medications. It is often prescribed with low-dose aspirin, but taking it with high-dose aspirin may decrease its effectiveness. Combining it with other blood thinners (anticoagulants like warfarin or heparin) or nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can increase the risk of bleeding. Certain medications can also affect Ticagrelor's levels: CYP3A4 inhibitors (like ketoconazole, clarithromycin) can increase its levels, while CYP3A4 inducers (like rifampin, phenytoin) can decrease its effectiveness. Inform your doctor about all medications, supplements, and herbal products you are taking.

What precautions should be taken while on TICACIP 90 MG TAB?

Do not stop taking TICACIP 90 MG TAB without consulting your doctor, as this can increase your risk of heart attack or stroke. Be cautious with activities that may lead to injury or bleeding, as this medication increases bleeding risk. Inform your doctor if you have a history of bleeding problems (including stomach ulcers or intracranial bleeding), severe liver disease, or if you have surgery planned.

What happens if a dose of TICACIP 90 MG TAB is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

How should TICACIP 90 MG TAB be stored?

Store TICACIP 90 MG TAB in a cool and dry place, away from direct sunlight and moisture, typically at room temperature (below 25°C or 30°C). Keep it out of reach of children.